We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Miss
Monica
Haritakis
+44 (0)1904 725459
yhs-tr.colocapstudy@nhs.net
Prof
James
Turvill
+44 (0)1904 725816
james.turvill@nhs.net
More information about this study, what is involved and how to take part can be found on the study website.
Colon capsule endoscopy diagnostic accuracy compared with as standard colonoscopy
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Colonoscopy is the current ‘gold standard’ method of diagnosing bowel disease. Here, a long, thin, flexible telescope is inserted, from the bottom, through the bowel by a trained healthcare worker. It is an uncomfortable procedure. Many patients need to be given intravenous sedation and/or pain relief to be able to cope with it. In the UK, the demand for colonoscopy exceeds the NHS's capacity to provide it. As a result, the diagnosis of a serious disease is being delayed. Colon capsule is a new technology that may be able to provide additional NHS capacity. It may also be better tolerated by some patients. The capsule is a camera in a pill that is swallowed, and which passes safely and usually painlessly through the bowel, taking pictures. It is the size of a large tablet, about 3cm long and 1cm wide, rounded at both ends with a smooth plastic casing. This makes it easy to swallow. It has a camera at each end to capture images of the bowel and a battery life of 10 hours. On average, after about 5 hours the capsule passes out naturally. It is disposable and can be flushed away safely down the toilet. A recorder needs to be worn around the waist to receive the capsule images. Later these are processed to create a report. As with colonoscopy, the bowel needs to be clean for the capsule test. This means that the day before either procedure, the patient will not be able to eat food, but will take clear fluids and purging laxatives. Many people find this the most difficult part of having a colonoscopy or capsule. On the day of the capsule, extra laxatives will need to be taken to help it pass through the bowel.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2025 Protocol article in https://pubmed.ncbi.nlm.nih.gov/41027693/ (added 01/10/2025)
You can take part if:
You may not be able to take part if:
1. Patients < 18 years2. Patients who are unable to safely swallow the CCE* 3. Patients who are unable to safely and fully comply with the bowel preparation* 4. Patients clinically at risk of stricturing bowel disease, such as Crohn’s disease5. Patients who have ever received abdominal or pelvic external beam radiotherapy6. Patients with a history of bowel obstruction7. Patients who have had a (partial) colectomy8. Patients who are currently pregnant or breastfeeding9. Symptomatic patients with suspected CRC who have not had a FIT within 3 months of referral10. Patients with a permanent pacemaker or other implanted electromedical device11. Patients who will not be able to safely tolerate the study* 12. Patients in whom the bowel preparation for CCE will likely be inadequate˟
* These exclusion criteria will require some clinical judgement in line with the existing approach to CCE and colonoscopy in clinical practice. Judgement of ability to tolerate the study requires an assessment of frailty per se, rather than a specific co-morbidity. However, it is likely to include patients with conditions such as cirrhosis, diabetes, stroke, peripheral vascular, heart or renal disease or cognitive impairment.
˟This exclusion criteria will also require some clinical judgement in line with the existing approach to CCE and colonoscopy in clinical practice. It will include patients with slow gastrointestinal motility, such as idiopathic slow transit constipation, those currently using opioid or tricyclic antidepressant medication, a history or prior poor bowel preparation and/or who require regular laxatives in their daily rounds.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Prof
James
Turvill
+44 (0)1904 725816
james.turvill@nhs.net
Miss
Monica
Haritakis
+44 (0)1904 725459
yhs-tr.colocapstudy@nhs.net
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by York Teaching Hospital NHS Foundation Trust and funded by National Institute for Health and Care Research.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 57318
You can print or share the study information with your GP/healthcare provider or contact the research team directly.